Differential effects of tumor necrosis factor-alpha co-administered with amyloid beta-peptide (25–35) on memory function and hippocampal damage in rat
- 1 December 2006
- journal article
- research article
- Published by Elsevier in Behavioural Brain Research
- Vol. 175 (2) , 352-361
Abstract
No abstract availableKeywords
Funding Information
- Russian Foundation for Basic Research (04-04-49488)
- Rochester Academy of Science
This publication has 56 references indexed in Scilit:
- Cholinergic treatment: what are the early neuropathological targets?European Journal of Neurology, 2005
- Synaptic plasticity disruption by amyloid β protein: modulation by potential Alzheimer's disease modifying therapiesBiochemical Society Transactions, 2005
- A β-induced TNF-α expression and acetylcholine action in mouse glial cellsLife Sciences, 2003
- Effects of tumor necrosis factor‐alpha central administration on hippocampal damage in rat induced by amyloid beta‐peptide (25–35)Journal of Neuroscience Research, 2002
- Memory deficits and increased emotionality induced by β-amyloid (25-35) are correlated with the reduced acetylcholine release and altered phorbol dibutyrate binding in the hippocampusJournal of Neural Transmission, 2001
- Multiple Pathways of Apoptosis in PC12 CellsJournal of Biological Chemistry, 1999
- Vitamin Ε as an Antioxidant/Free Radical Scavenger Against Amyloid β-Peptide-Induced Oxidative Stress in Neocortical Synaptosomal Membranes and Hippocampal Neurons in Culture: Insights into Alzheimer's DiseaseReviews in the Neurosciences, 1999
- Tumor necrosis factor α augments amyloid β protein (25–35) induced apoptosis in human cellsNeuroscience Letters, 1997
- Mechanisms of Neuronal Degeneration in Alzheimer's DiseaseNeuron, 1996
- Neurotrophic and Neurotoxic Effects of Amyloid β Protein: Reversal by Tachykinin NeuropeptidesScience, 1990